NEAT1 remodeling rewires the MYC degradation pathway
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkag1015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Hagoon Jang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pediatrics and Genetics, Stanford University, Stanford, CA 94305, United States. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Ubiquitin-Protein Ligases, RNA, Long Noncoding. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
MYC is among the most frequently amplified oncogenes in human cancer, yet its intrinsically disordered nature has rendered it refractory to direct pharmacological targeting. Here, we demonstrate that the long noncoding RNA NEAT1_1 functions as a molecular gatekeeper that controls MYC protein stability by regulating its access to the E3 ubiquitin ligase UBR5. We show that NEAT1_1 forms a ribonucleoprotein (RNP) complex with both MYC and UBR5, and that NEAT1_1 suppression disrupts this interaction, leading to decreased MYC polyubiquitination and enhanced protein stability. To systematically map the regulatory architecture of NEAT1_1 without altering its abundance, we screened 88 antisense oligonucleotide (ASO) mixmers tiling across the transcript. Strikingly, this phenotypic screen identified region-specific mixmers that elicit bidirectional control over MYC, either driving robust MYC destabilization or promoting its stabilization in a strictly expression-independent manner. Mechanistically, MYC-destabilizing mixmers selectively enhance the interaction between MYC and UBR5 to accelerate proteasomal degradation. A focused CRISPR screen targeting the ubiquitin–proteasome pathway independently validated UBR5 as the essential E3 ligase mediating this mixmer-induced turnover. In vivo, our lead mixmer ASO_#24 significantly suppressed tumor growth in MYC-high xenografts, whereas MYC-low tumors remained unaffected. Our findings reveal that the functional output of a scaffold lncRNA is encoded in its sub-domain architecture rather than bulk transcript levels, establishing domain-specific RNA targeting as a tractable strategy to rewire protein turnover pathways for otherwise undruggable oncogenes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Pediatrics and Genetics, Stanford University, Stanford, CA 94305, United States.
- Department of Surgery, School of Medicine, Stanford University, Stanford, CA 94304, United States.
ORCID-Profile: Bo Kyoung Suh, Mark A Kay
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Jang, H., Suh, B. K., Zhang, F., Lin, A., Tan, M., Liu, Y., Chua, M. S., So, S., & Kay, M. A. (2026). NEAT1 remodeling rewires the MYC degradation pathway. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag1015
Vancouver
Jang H, Suh BK, Zhang F, Lin A, Tan M, Liu Y, et al. NEAT1 remodeling rewires the MYC degradation pathway. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag1015
BibTeX
@article{Jang2026,
author = {Jang, Hagoon and Suh, Bo Kyoung and Zhang, Feijie and Lin, Angela and Tan, Mingdian and Liu, Yi and Chua, Mei-Sze and So, Samuel and Kay, Mark A},
title = {NEAT1 remodeling rewires the MYC degradation pathway},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag1015}
}
EUVIMED